Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit
- PMID: 3710068
- DOI: 10.1016/0016-5085(86)90457-9
Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit
Abstract
Nor-ursodeoxycholate, the C23 analogue of ursodeoxycholate, is a potent choleretic agent in rodents when given acutely but, to be used in humans, chronic toxicity studies are required. In the rabbit, ingestion of ursodeoxycholate or chenodeoxycholate leads to accumulation of lithocholate, its major bacterial metabolite, in biliary bile acids, which causes inflammation in portal tracts of the liver and bile duct proliferation. To test whether chronic administration of nor-ursodeoxycholate would cause an analogous accumulation of nor-lithocholate and hepatotoxicity, rabbits were fed a Chow diet containing nor-ursodeoxycholate (5 or 50 mg/day): control groups received Chow alone, and "disease control" groups received Chow plus ursodeoxycholate or Chow plus chenodeoxycholate. After 3 wk, animals were killed, liver sections were interpreted by a pathologist, and the steroid moiety of the glycine (and taurine) conjugates of gallbladder bile acids were analyzed by high-pressure liquid chromatography. Ingestion of nor-ursodeoxycholate did not cause hepatotoxicity, and neither it nor its presumed metabolite, nor-lithocholate, accumulated in biliary bile acids. To explain this unexpected finding, the hepatic metabolism of nor-ursodeoxycholate was investigated in biliary fistula rabbits. Nor-ursodeoxycholate was well absorbed from the intestine and secreted in the bile as a glucuronide as well as the unchanged compound, but conjugation with glycine and taurine was not observed. As glucuronides are poorly absorbed from the gut, it is proposed that the hepatic biotransformation of nor-ursodeoxycholate to a glucuronide rather than to a glycine amidate in the liver prevented its accumulation in the bile acid pool. Thus, shortening the side chain of ursodeoxycholate by a single carbon atom resulted in a bile acid with novel metabolism, which when administered chronically, does not accumulate in the enterohepatic circulation and does not cause hepatotoxicity.
Similar articles
-
Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.Lab Invest. 1982 Apr;46(4):428-37. Lab Invest. 1982. PMID: 7200166
-
Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N-methyl amino acids.Hepatology. 1990 Jun;11(6):989-96. doi: 10.1002/hep.1840110613. Hepatology. 1990. PMID: 2365296
-
Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.Gastroenterology. 1986 Apr;90(4):837-52. doi: 10.1016/0016-5085(86)90859-0. Gastroenterology. 1986. PMID: 3949115
-
Pharmacology of ursodeoxycholic acid, an enterohepatic drug.Scand J Gastroenterol Suppl. 1994;204:1-15. doi: 10.3109/00365529409103618. Scand J Gastroenterol Suppl. 1994. PMID: 7824870 Review.
-
Clinical pharmacokinetics of therapeutic bile acids.Clin Pharmacokinet. 1996 May;30(5):333-58. doi: 10.2165/00003088-199630050-00002. Clin Pharmacokinet. 1996. PMID: 8743334 Review.
Cited by
-
Biology of Cholangiocytes: From Bench to Bedside.Gut Liver. 2016 Sep 15;10(5):687-98. doi: 10.5009/gnl16033. Gut Liver. 2016. PMID: 27563020 Free PMC article. Review.
-
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.World J Exp Med. 2025 Mar 20;15(1):101771. doi: 10.5493/wjem.v15.i1.101771. eCollection 2025 Mar 20. World J Exp Med. 2025. PMID: 40115760 Free PMC article. Review.
-
Differential effects of norUDCA and UDCA in obstructive cholestasis in mice.J Hepatol. 2013 Jun;58(6):1201-8. doi: 10.1016/j.jhep.2013.01.026. Epub 2013 Jan 29. J Hepatol. 2013. PMID: 23369794 Free PMC article.
-
Effect of different doses of ursodeoxycholic acid in chronic liver disease.Dig Dis Sci. 1989 Dec;34(12 Suppl):59S-65S. doi: 10.1007/BF01536665. Dig Dis Sci. 1989. PMID: 2598769 Clinical Trial.
-
Current concepts of biliary secretion.Dig Dis Sci. 1989 Dec;34(12 Suppl):16S-20S. doi: 10.1007/BF01536657. Dig Dis Sci. 1989. PMID: 2689114 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials